Abstract:In recent days, novel biomolecule stabilized nanocomposites have come into prominence as featured next generation materials. In this article we have green synthesized Au nanoparticles being deposited and stabilized over chitosan (CS) molecules. The electron rich polar functional groups of chitosan have been exploited to cap the Au NPs. The structural and physical features of Au NPs-CS nanocomposite was analyzed with different techniques like Ultraviolet–Visible Spectroscopy, Fourier Transform Infrared Spectroscopy, Field Emission Scanning Electron Microscope, Transmission Electron Microscopy, and Energy-Dispersive X-Ray Spectroscopy techniques. Recently, noble metal nanoparticles have been used in the treatment of different cancers. This has prompted us to use our nanocomposite in the treatment of acute myeloid leukemia (AML) both in vitro and in vivo. Initially, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay was performed to study the excellent antioxidant properties of Au NPs-CS nanocomposite. For in vitro cytotoxicity studies, HUVEC normal cell line, 32D-FLT3-ITD and Murine C1498 cancer cell lines were used and the nanocomposite was found of comparable potential as the standard AML drug Daunorubicin. For in vivo studies, 7,12-Dimethylbenz[a]anthracene (DMBA) was injected for inducing AML over 50 mice and then the drug as well as the nanocomposite was administered. Subsequently, comparison of different immunological, hematological, biochemical, stereological parameters and S1PR1 and S1PR5 mRNA expressions were ascertained. By quantitative real-time polymerase chain reaction, S1PR1 and S1PR5 mRNA expression in lymphocytes were significantly (<em>p</em>≤0.05) raised by treating the leukemic mice with the nanocomposite. Also, nanocomposite significantly (<em>p</em>≤0.05) decreased the weight and volume of liver and spleen, the pro-inflammatory cytokines, and the total white blood cells, blast, neutrophil, monocyte, eosinophil, and basophil counts, increased the anti-inflammatory cytokines and the lymphocyte, platelet and red blood cells parameters, and regulated the biochemical parameters as compared to the untreated mice. An extensive study was done on these biological experiments using the Au NPs-CS nanocomposite and we achieved fascinating results such that it could be used as an alternative prospective chemotherapeutic drug for the treatment of acute myeloid leukemia.

Synthesis and application of Au NPs-chitosan nanocomposite in the treatment of acute myeloid leukemia in vitro and in vivo

Nano-drug Delivery System for the Treatment of Acute Myelogenous Leukemia.

Synthesis of gold Nanoparticles Encapsulated Chitosan/Gelatin Polymers for the Treatment of Several Types of Leukemia

Novel Strategy to Fabricate PLA/Au Nanocomposites As an Efficient Drug Carrier for Human Leukemia Cells in Vitro

Formulation of a novel anti-leukemia drug and evaluation of its therapeutic effects in comparison with Cytarabine

A Green Synthesis of Au-Ag Alloy Nanoparticles using Polydopamine Chemistry: Evaluation of their Anticancer Potency Towards Both MCF-7 Cells and their Cancer Stem Cells Subgroup

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

The Cellular Uptake and Cytotoxic Effect of Silver Nanoparticles on Chronic Myeloid Leukemia Cells.

Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.

Hollow Mesoporous Prussian Blue Nanoparticles Loaded with Daunorubicin for Acute Myeloid Leukemia Treatment

CXCR4 and CD44 Dual-Targeted Prussian Blue Nanosystem with Daunorubicin Loaded for Acute Myeloid Leukemia Therapy

Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia

The Potential for Clinical Translation of Antibody-Targeted Nanoparticles in the Treatment of Acute Myeloid Leukaemia

Coomassie Bright Blue-Conjugated Human Serum Albumin Nanoparticles As a Tumor-Selective Weapon for Leukemia Therapy

Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery

Targeting Epigenetic Pathway with Gold Nanoparticles for Acute Myeloid Leukemia Therapy

Effect of Colloidal Gold Nanoparticles on Cell Interface and Their Enhanced Intracellular Uptake of Arsenic Trioxide in Leukemia Cancer Cells.

Nanotechnology-assisted combination drug delivery: a progressive approach for the treatment of acute myeloid leukemia

Biocompatible silver, gold and silver/gold alloy nanoparticles for enhanced cancer therapy: in vitro and in vivo perspectives

The Use of Nanocarriers in Acute Myeloid Leukaemia Therapy: Challenges and Current Status

Fe3O4-Coated CNTs-Gum Arabic Nano-Hybrid Composites Exhibit Enhanced Anti-Leukemia Potency Against AML Cells via ROS-Mediated Signaling